FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of ...

Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound(TM) Product from Sequence LifeScience, Inc.

(Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial products ...

The extracellular matrix (ECM) is a key element of tissues and organs. It maintains their structure and provides biochemical and mechanobiological signals to the cells, having a prominent role in ...

FLORHAM PARK, N.J., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial ...

Keywords: Biomaterials, Nanomedicine, Nanostructures, Drug delivery, Theranostics, Regeneration Surface engineering, Personalized therapy Important Note: All contributions to this Research Topic must ...